Literature DB >> 8575003

Signalling mechanisms in the regulation of vascular cell migration.

H Abedi1, I Zachary.   

Abstract

The migration of arterial vascular smooth muscle cells (VSMC) is thought to play a central role in atherogenesis and restenosis. The migration of several other cell types, including monocytes, T-lymphocytes and endothelial cells is also involved in the development of the mature atherosclerotic lesion. Several defined growth factors, cytokines and extracellular matrix components which are released at the sites of lesions have been implicated in the regulation of migration of VSMC and other lesion-associated cells. Platelet-derived growth factor BB-homodimer of PDGF (PDGF-BB) is strongly implicated in neo-intima formation in vivo and is the most potent known chemoattractant for VSMC in vitro. Dynamic interactions between cell surface adhesive receptors (integrins) for ECM components, organisation of the actin cytoskeleton and the turnover of focal adhesions are all key processes in cell locomotion and migration. The signal transduction pathways which mediate the chemotactic effects of PDGF-BB and other migration factors on VSMC are unknown, but several classes of cellular components are implicated including components associated with focal adhesions, small GTP-binding proteins of the rho family, and certain substrates of the PDGF beta-receptor. Tyrosine phosphorylation of the novel focal adhesion-associated protein tyrosine kinase, p125 focal adhesion kinase (p125FAK), is regulated by integrins and by several factors which alter actin cytoskeletal organisation. Recent findings suggest that tyrosine phosphorylation of p125FAK and other focal adhesion-associated proteins may be implicated in the chemotactic response of VSMC to PDGF-BB. The migratory response to PDGF-BB may be dependent on both ligand isoform bio-availability and on receptor-isotype expression as well as on down-stream signalling events. Ultimately, cell migration in vivo will be determined by a complex array of diverse extracellular molecules organised in intercellular paracrine/autocrine networks as well as multiple interacting intracellular signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575003

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  32 in total

Review 1.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

2.  Effects and mechanism of flavonoids from Astragalus complanatus on breast cancer growth.

Authors:  Jinhai Zhu; Hui Zhang; Zhengzhi Zhu; Qiong Zhang; Xiaokai Ma; Zhen Cui; Tingjing Yao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-04-24       Impact factor: 3.000

3.  Overexpression of mimecan in human aortic smooth muscle cells inhibits cell proliferation and enhances apoptosis and migration.

Authors:  Hui-Jie Zhang; Jing Wang; Hui-Fang Liu; Xiao-Na Zhang; Ming Zhan; Feng-Ling Chen
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

4.  Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.

Authors:  Magnus Bäck; De-xiu Bu; Robert Bränström; Yuri Sheikine; Zhong-Qun Yan; Göran K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

5.  Regulation of the spatial organization of mesenchymal connective tissue: effects of cell-associated versus released isoforms of platelet-derived growth factor.

Authors:  S A Eming; M L Yarmush; G G Krueger; J R Morgan
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

6.  Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells.

Authors:  J M Taylor; C P Mack; K Nolan; C P Regan; G K Owens; J T Parsons
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Diverse activity of human secretory phospholipases A2 on the migration of human vascular smooth muscle cells.

Authors:  W Pruzanski; J Kopilov; A Kuksis
Journal:  Inflamm Res       Date:  2015-05-22       Impact factor: 4.575

8.  Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury.

Authors:  Chun Huang; Jong Sun Chang; Yunlu Xu; Qing Li; Yu Shan Zou; Shi-Fang Yan
Journal:  Atherosclerosis       Date:  2010-06-04       Impact factor: 5.162

9.  Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.

Authors:  S Wijetunge; J S Lymn; A D Hughes
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

10.  Early intracellular signalling pathway of ethanol in vascular smooth muscle cells.

Authors:  A Sachinidis; I Gouni-Berthold; C Seul; S Seewald; Y Ko; U Schmitz; H Vetter
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.